l 158809 has been researched along with Focal Segmental Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fogo, A; Ichikawa, I; Patel, A; Peten, EP; Striker, GE; Striker, LJ | 1 |
| Bos, H; De Boer, E; De Jong, PE; De Zeeuw, D; Henning, RH; Navis, G; Tiebosch, AT | 1 |
2 other study(ies) available for l 158809 and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
The molecular basis of increased glomerulosclerosis after blockade of the renin angiotensin system in growth hormone transgenic mice.
Topics: Actins; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Base Sequence; Blood Pressure; Body Weight; Captopril; Collagen; Collagenases; Creatinine; Disease Models, Animal; Extracellular Matrix; Gelatinases; Glomerular Filtration Rate; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Growth Hormone; Imidazoles; Juxtaglomerular Apparatus; Kidney; Kidney Glomerulus; Lymphotoxin-alpha; Mice; Mice, Transgenic; Muscle, Smooth; Organ Size; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Thymidine | 1994 |
Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antineoplastic Agents; Blood Pressure; Body Weight; Disease Models, Animal; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Imidazoles; Lisinopril; Male; Nephrosis; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles | 2002 |